Andre L. Simao
Lisbon, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
E2F2 transcription factor promotes a cholestatic MASH phenotype by regulating hepatobiliary metabolism through miR-34a-5p.
Journal: Hepatology (Baltimore, Md.)
Published: January 30, 2025
Depression- and exercise-associated stimuli exert contrasting effects on neural stem cell activity and paracrine signaling.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: September 16, 2024
Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1.
Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1.
Journal: JHEP reports : innovation in hepatology
Published: February 18, 2023
miR-21-5p promotes NASH-related hepatocarcinogenesis.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: January 27, 2023
Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease.
Journal: JHEP reports : innovation in hepatology
Published: November 07, 2022
Isolation of Mitochondria from Liver and Extraction of Total RNA and Protein: Analyses of miRNA and Protein Expression.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: June 07, 2021
Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics.
Journal: Aging
Published: May 24, 2021
Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning?
Journal: Journal of clinical medicine
Published: March 28, 2020
Skeletal muscle miR-34a/SIRT1:AMPK axis is activated in experimental and human non-alcoholic steatohepatitis.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: November 10, 2018
miRNA-21 ablation protects against liver injury and necroptosis in cholestasis.
Journal: Cell death and differentiation
Published: August 07, 2017
miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice.
Journal: Cell death & disease
Published: May 26, 2017
Last Updated: 09/26/2026